PALISADE BIO, INC. — Director's Dealing 2014

Feb 13, 2014

SEC Form 4/A — Form 4/A

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-01-24

Reporting Person: GARR RICHARD (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-24	Common Stock	M	400000	$0.50	Acquired	1455327	Direct
2014-01-24	Common Stock	F	65789	$3.04	Disposed	1389538	Direct
2014-01-24	Common Stock	F	140201	$3.04	Disposed	1249337	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-24	Common Stock Purchase Option	$0.50	M	400000	Acquired	2015-07-28	Common Stock (400000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	252000	Indirect

Footnotes

F1: Represents shares issued / cancelled upon the cashless exercise of an option to purchase 400,000 shares of Common Stock at an exercise price of $0.50 per share using a fair market value of the Issuer's stock on 1/24/2014 of $3.04.

F2: Represents the shares of Common Stock withheld to satisfy the reporting person's tax withholding obligation upon exercise of Common Stock Purchase Option. The deemed disposition of the withheld shares is exempt pursuant to Rule 16b-3.

F3: Reporting Person disclaims all interest, including pecuniary, of securities. Securities are held in spouse's name as her "sole and separate" property.

F4: Represents the cashless exercise of an option to purchase shares of Common Stock at an exercise price of $0.50.

F5: Right to Buy.